Luminex to acquire GenturaDx for $50 million
Luminex Corp. agrees to buy the molecular diagnostics company in a cash deal designed to expand Luminex's presence in the market
To continue reading this article, subscribe for FREE to
Subscribe today to keep up to date with the latest advancements and discoveries in drug development achieved by scientists in pharma, biotech, non-profit, academic, clinical, and government labs.
About the Author
- This person does not yet have a bio.
Related Topics
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
SubscribeSponsored
Explore how a needs-driven approach to electronic laboratory notebook selection can improve data integrity, reproducibility, and scientific continuity.
Learn the fundamental weighing principles and operational controls that support reliable sample preparation.
Can animal testing be replaced? Discover how scientists are developing more human-relevant ways to predict drug toxicity earlier.
